Reactome: A Curated Pathway Database
THIS SITE IS USED FOR CURATION AND TESTING
IT IS NOT STABLE, IS LINKED TO AN INCOMPLETE DATA SET, AND IS NOT MONITORED FOR PERFORMANCE. WE STRONGLY RECOMMEND THE USE OF OUR PUBLIC SITE

Query author contributions in Reactome

Reactome depends on collaboration between our curation team and outside experts to assemble and peer-review its pathway modules. The integration of ORCID within Reactome enables us to meet a key challenge with authoring, curating and reviewing biological information by incentivizing and crediting the external experts that contribute their expertise and time to the Reactome curation process. More information is available at ORCID and Reactome.

If you have an ORCID ID that is not listed on this page, please forward this information to us and we will update your Reactome pathway records.

Name Email address

Details on Person Inhibition of microsomal triglyceride transfer protein alone or with ezetimibe in patients with moderate hypercholesterolemia

Class:IdLiteratureReference:9737763
_displayNameInhibition of microsomal triglyceride transfer protein alone or with ezetimibe in patients with moderate hypercholesterolemia
_timestamp2021-07-22 14:07:03
author[Person:9737782] Samaha, Frederick F
[Person:9737755] McKenney, James
[Person:9737745] Bloedon, Leanne T
[Person:9735887] Sasiela, William J
[Person:5244651] Rader, Daniel J
created[InstanceEdit:9737790] Jassal, Bijay, 2021-07-22
journalNat Clin Pract Cardiovasc Med
pages497-505
pubMedIdentifier18506154
titleInhibition of microsomal triglyceride transfer protein alone or with ezetimibe in patients with moderate hypercholesterolemia
volume5
year2008
(literatureReference)[Summation:9737768] The microsomal triglyceride transfer protein (MTTP) is requi...
[RegulationReference:9748631] Negative regulation by 'MTTP:lomitapide [endoplasmic reticulum lumen]' Inhibition of microsomal triglyceride transfer protein in familial hypercholesterolemia
[Change default viewing format]
No pathways have been reviewed or authored by Inhibition of microsomal triglyceride transfer protein alone or with ezetimibe in patients with moderate hypercholesterolemia (9737763)